有效的组合化学-声动力学癌症疗法使用线粒体向声敏化剂加载多酸盐基菌体
Hyeon Ju Kang1, Quan Truong Hoang1, Jun Min1
1Department of Nano-Bioengineering, Incheon National University, Incheon 22012, Republic of Korea.
International journal of molecular sciences
|March 28, 2024
概括
这项研究开发了Tween 80 (T80) 微粒,以改善用于声动疗 (SDT) 的声敏化剂的传递. T80微粒增强了癌细胞的吸收并触发了亡,显示了针对癌症治疗的希望.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 声动疗 (SDT) 为深层瘤提供非侵入性治疗,但在声敏剂稳定性和细胞吸收方面面临挑战.
- 开发有效的纳米载体对于克服这些局限性和推进SDT临床转化至关重要.
研究的目的:
- 为了配制基于Tween 80 (T80) 的粒来增强对线粒体向的三 (TPP) 结合e6 (T-Ce6) 声敏剂的传递.
- 为了研究化学-光动力学疗法的组合,使用共同封装的piperlongumine (PL) 进行协同作用的抗癌作用.
主要方法:
- 针对线粒体的TPP结合e6 (T-Ce6) 和 piperlongumine (PL) 被装入T80小粒体中.
- 细胞吸收,活性氧物种 (ROS) 生成和亡在超声波 (US) 暴露后在MCF-7乳腺癌细胞中进行了评估.
主要成果:
- T80微粒显著改善了T-Ce6.6的细胞内化.
- T80(T-Ce6/PL) 细胞增强了细胞内ROS生成,并选择性地积聚在线粒体中,导致有效的美国诱导的细胞死亡.
- 组合疗法通过PL触发了癌症特异性亡,证明了向细胞死亡机制.
结论:
- T80微粒是有效的纳米载体的sonosensitizers,提高他们的交付和有效性在音频动力学疗法.
- 开发的T80 (T-Ce6 / PL) 细胞显示了高效的癌症特异性组合化疗-SDT的潜力,为向癌症治疗提供了一个有前途的战略.
更多相关视频
07:32Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
11.3K
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.1K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:46Electron Transport Chain: Complex I and II
13.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.2K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K